Chardan Capital Lowers Metagenomi (NASDAQ:MGX) Price Target to $12.00
Metagenomi (NASDAQ:MGX – Free Report) had its price objective reduced by Chardan Capital from $13.00 to $12.00 in a research note released on Thursday morning,Benzinga reports. They currently have a buy rating on the stock. A number of other equities analysts have also weighed in on the company. HC Wainwright dropped their price objective on […]
Metagenomi (NASDAQ:MGX – Free Report) had its price objective reduced by Chardan Capital from $13.00 to $12.00 in a research note released on Thursday morning,Benzinga reports. They currently have a buy rating on the stock. A number of other equities analysts have also weighed in on the company. HC Wainwright dropped their price objective on […]
